IP Library Granted Patent US 7,029,885
Granted Patent B2
US 7,029,885 · App. 09/457,765 · Granted Apr 18, 2006

Process for the preparation of ampicillin

Assignee: DSM IP Assests B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,029,885
App. No.
09/457,765
Granted
Apr 18, 2006
Kind
B2
Abstract

Ampicillin is produced in a batch process by enzymatic acylation of 6-aminopenicillanic acid (6-APA) with the aid of phenylglycine derivative such as D-phenylglycine amide. High conversions of phenylglycine derivative may be achieved by having the total concentration in the reaction mixture of 6-APA and ampicillin greater than 250 mM and the molar ration of total quantity of phenylglycine derivative to total quantity of 6-APA less than 2.5. Higher yields of ampicillin may be achieved when the amount of dissolved 6-APA is kept low, e.g. below 300 mM.

Claims (18)

1. A process for preparation of ampicillin comprising:

acylating 6-aminopenicillanic acid (6-APA) with a phenylglycine derivative and an enzyme to form a reaction mixture wherein the process is carried out while

i) the total concentration in the reaction mixture of 6-APA and ampicillin combined is substantially throughout the reaction, greater than 250 mM;

ii) metering in partially the 6-APA and/or the phenylglycine derivative in the course of the acylation reaction to thereby maintain the concentration of dissolved 6-APA lower than 300 mM throughout the reaction; and

iii) the molar ratio of the total quantity of phenylglycine derivative to the total quantity of 6-APA is less than 2.5.

2. Process according to claim 1 , wherein the acylation reaction is carried out while the total concentration of the 6-APA and ampicillin present in the reaction mixture is, substantially throughout the reaction, greater than 300 mM.

3. Process according to any one of claims 1 or 2 , wherein the acylation reaction is carried out while metering in partially the 6-APA and/or the phenylglycine derivative to thereby maintain the concentration of dissolved 6-APA lower than 250 mM throughout the reaction.

4. Process according to claim 1 , wherein the acylation reaction is carried out while the molar ratio of the total quantity of phenylglycine derivative to the total quantity of 6-APA is less than 2.0.

5. Process according to claim 1 , wherein the phenylglycine derivative is metered in as a salt of D-phenylglycine amide and an acid.

6. Process according to claim 5 , wherein the phenylglycine derivative is metered in the form of a solution of D-phenylglycine amide, 1/2 H 2 SO 4 in water.

7. Process according to claim 1 , which comprises charging a portion of the total amount of 6-APA to the reaction mixture at the beginning of the reaction such portion providing a concentration of dissolved 6-APA less than 300 mM and introducing the remainder of the total amount during the remainder of the acylation reaction to maintain the concentration of dissolved 6-APA less than 300 mM.

8. Process according to claim 7 , wherein the concentration of dissolved 6-APA is kept lower than 250 mM throughout the acylation reaction.

9. Process according to claim 8 , wherein the total concentration of the 6-APA and ampicillin present in the reaction mixture is, substantially throughout the acylation reaction, greater than 300 mM.

10. A process for the preparation of ampicillin by acylating a quantity of 6-aminopenicillanic acid (6-APA) with a quantity of phenylglycine derivative and an enzyme in an aqueous reaction medium to provide a reaction mixture containing dissolved 6-APA; said process comprising

initially introducing a part of said quantity of the 6-APA and/or a part of the quantity of phenylglycine derivative into the reaction medium under conditions allowing ampicillin to be formed by the acylation reaction and,

thereafter adding the rest of the quantity of 6-APA and/or phenylglycine derivative, under conditions whereby ampicillin will continue to be formed by the acylation reaction, and

wherein the concentration of dissolved 6-APA in the reaction mixture is, throughout the acylation reaction, lower than 300 mM and the total combined concentrations in the reaction mixture of 6-APA and formed ampicillin is greater than 250 mM; and further

wherein the molar ratio of the quantity of phenylglycine derivative to the quantity of 6-APA is less than 2.5.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2012
From: DSM IP ASSETS B.V.
To: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.
Reel/Frame 028638/0272 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2003
From: DSM N.V.
To: DSM IP ASSETS B.V.
Reel/Frame 014634/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2000
From: MOODY, HAROLD M.; BOESTEN, WILHELMUS H.J.
To: DSM N.V.
Reel/Frame 010545/0826 →
Priority Claims (1)
NL 1006266 · Jun 10, 1997 · national
Continuity (2)
Continuation PCTNL980029500 · May 25, 1998
Related Publication 20020009769A1 · Jan 24, 2002